Table 1.
Patient number | Status | Age | Sex | Genotype | FEV1 (%) | Microbiology | Antibiotic and/or modulator therapy |
---|---|---|---|---|---|---|---|
1 | CF | 18 | Male | F508del/Y1092X | 77 | S. aureus many mixed | None |
2 | CF | 24 | Male | F508del/F508del | 96 | S. aureus | Aztreonam, colistimethate, doxycycline, ivacaftor/lumacaftor |
3 | CF | 28 | Female | F508del/F508del | 91 | A. xylosoxidans moderate mixed | Colistimethate, tobramycin |
4 | CF | 18 | Female | F508del/F508del | 88 |
S. aureus many mixed A. xylosoxidans, moderate mixed |
Colistimethate, tobramycin, ivacaftor/lumacaftor |
5 | Healthy | 26 | Female | ||||
6 | Healthy | 33 | Male | ||||
7 | Healthy | 25 | Female | ||||
8 | Healthy | 20 | Female |
S. aureus Staphylococcus aureus, A. xylosoxidans Achromobacter xylosoxidans